USA flag logo/image

An Official Website of the United States Government

Novel Treatment of Keloids and Hypertrophis Scars

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
71286
Program Year/Program:
2004 / SBIR
Agency Tracking Number:
AR049972
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
BIOMEDICAL DEVELOPMENT CORPORATION
A152 ASTeCC Building Lexington, KY 40506-
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2004
Title: Novel Treatment of Keloids and Hypertrophis Scars
Agency: HHS
Contract: 1R43AR049972-01A1
Award Amount: $113,828.00
 

Abstract:

DESCRIPTION (provided by applicant): Treatment of hypertrophic scars and keloids is time consuming, expensive, and has few consistently successful approaches. Hypertrophic scars and keloids are often treated with intralesional injection, pressure therapy, or excision. Unfortunately, these treatment modalities are invasive, painful, or inconvenient, and often unsuccessful. Silicone gel sheeting has been used successfully in the treatment of scarring, but the dressings can be difficult to affix and are associated with local side effects and cosmetic deficiencies that negatively impact compliance and patient satisfaction. The goal of this project is to demonstrate the feasibility of using a novel film forming technology as an alternative to silicone sheeting for the treatment of hypertrophic scars and keloids. This project offers an innovative polymer-based technology to overcome the limitations of silicone sheeting. The product is expected to be commercially successful based on its inherent low cost, ease of use, superior cosmetic attributes, and improved outcomes. The following specific aims will be pursued: Specific Aim 1. Formulate Coatings for the Treatment of Hypertrophic Scars and Keloids Specific Aim 2. Demonstrate Efficacy of Coatings in a Human Clinical Trial.

Principal Investigator:

Bakul M. Bhatt
2103080636
BHATT@BIODEVCORP.COM

Business Contact:

Gregg Siegel
2103080636
GSIEGEL@BIODEVCORP.COM
Small Business Information at Submission:

BIOMEDICAL DEVELOPMENT CORPORATION
BIOMEDICAL DEVELOPMENT CORP 500 SANDAU, STE 200 SAN ANTONIO, TX 78216

EIN/Tax ID: 742330067
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No